A Systematic Review of Bone Graft Products Used in Lumbar Interbody Fusion Procedures for Degenerative Disc Disease

Overview

Journal N Am Spine Soc J

Date 2025 Feb 7

PMID 39917175

Authors

Anita Fitzgerald

Rachael McCool

Emma Carr

Paul Miller

Katie Reddish

Cynthia C Lohr

Elena Annoni

Brandon Lawrence

Affiliations

Soon will be listed here.

Abstract

Background: Degenerative disc disease (DDD) is associated with chronic lower back pain that may have impacts on individual's quality of life and functional ability. Lumbar interbody fusion can be carried out with a variety of bone grafting products, the choice depends on several factors including the patient, site, procedure, cost and indication. This systematic review (SR) intends to validate and consolidate the existing evidence base supporting bone graft materials related to lumbar interbody fusion procedures for DDD, specifically anterior lumbar interbody fusion (ALIF) and oblique lumbar interbody fusion (OLIF).

Methods: An SR was conducted in February 2023. Clinical and economic studies of adults with DDD in regions L2 to S1 undergoing lumbar interbody fusion with Infuse™, allograft, synthetic bone grafts, demineralized bone matrices or cell-based matrices were eligible for inclusion.

Results: Twenty-one studies (reported in 25 publications) were included in the review. Eighteen studies (reported in 22 publications) reported clinical outcomes, while 4 studies reported economic outcomes. Nine studies (in 5 publications) investigated Infuse™, including 3 randomized controlled trials (RCTs), one cohort study and 4 case series. Ten studies investigated allograft bone, bone harvested from the vertebral spur combined with apacerum powder, or tricalcium phosphate soaked in autologous bone marrow aspirate, including one RCT, 2 cohort studies, and 7 case series.

Conclusions: The SR shows that Infuse™ offers comparable results to iliac crest bone graft with the benefit of not requiring harvested bone and offers significant benefits in surgical time and blood loss. There is a lack of comparative evidence for any other bone grafts identified in this SR, highlighting the need for further well-designed studies to be conducted in this area.

References

Abbasi H, Abbasi A . Oblique Lateral Lumbar Interbody Fusion (OLLIF): Technical Notes and Early Results of a Single Surgeon Comparative Study. Cureus. 2015; 7(10):e351. PMC: 4652919. DOI: 10.7759/cureus.351. View

Lee N, Kim K, Yi S, Ha Y, Shin D, Yoon D . Comparison of Outcomes of Anterior, Posterior, and Transforaminal Lumbar Interbody Fusion Surgery at a Single Lumbar Level with Degenerative Spinal Disease. World Neurosurg. 2017; 101:216-226. DOI: 10.1016/j.wneu.2017.01.114. View

Kenneth Burkus J, Heim S, Gornet M, Zdeblick T . Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech. 2003; 16(2):113-22. DOI: 10.1097/00024720-200304000-00001. View

Vaz K, Verma K, Protopsaltis T, Schwab F, Lonner B, Errico T . Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications. SAS J. 2015; 4(3):75-86. PMC: 4365636. DOI: 10.1016/j.esas.2010.01.004. View

Zhao H, Gao H, Zhou C, Qian S, Yuan Y, Xue W . A randomized controlled trial with ≥5 years of follow-up comparing minimally invasive and open transforaminal lumbar interbody fusion in disc herniation at single level. Exp Ther Med. 2019; 17(5):3614-3620. PMC: 6447782. DOI: 10.3892/etm.2019.7368. View

Kenneth Burkus J, Transfeldt E, Kitchel S, Watkins R, Balderston R . Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976). 2002; 27(21):2396-408. DOI: 10.1097/00007632-200211010-00015. View

Deane J, McGregor A . Current and future perspectives on lumbar degenerative disc disease: a UK survey exploring specialist multidisciplinary clinical opinion. BMJ Open. 2016; 6(9):e011075. PMC: 5030539. DOI: 10.1136/bmjopen-2016-011075. View

Kleeman T, Ahn U . Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine (Phila Pa 1976). 2001; 26(24):2751-6. DOI: 10.1097/00007632-200112150-00026. View

Chung S, Lee S, Lim S, Kim D, Jang J, Nam K . Comparative study of laparoscopic L5-S1 fusion versus open mini-ALIF, with a minimum 2-year follow-up. Eur Spine J. 2003; 12(6):613-7. PMC: 3467988. DOI: 10.1007/s00586-003-0526-y. View

10.

Benoist M . Natural history of the aging spine. Eur Spine J. 2003; 12 Suppl 2:S86-9. PMC: 3591827. DOI: 10.1007/s00586-003-0593-0. View

11.

Kalb S, Perez-Orribo L, Kalani M, Snyder L, Martirosyan N, Burns K . The Influence of Common Medical Conditions on the Outcome of Anterior Lumbar Interbody Fusion. Clin Spine Surg. 2013; 29(7):285-90. DOI: 10.1097/BSD.0b013e31827e4c85. View

12.

Choi J, Sung K . Subsidence after anterior lumbar interbody fusion using paired stand-alone rectangular cages. Eur Spine J. 2005; 15(1):16-22. PMC: 3454564. DOI: 10.1007/s00586-004-0817-y. View

13.

Sarwat A, OBrien J, Renton P, Sutcliffe J . The use of allograft (and avoidance of autograft) in anterior lumbar interbody fusion: a critical analysis. Eur Spine J. 2001; 10(3):237-41. PMC: 3611495. DOI: 10.1007/s005860000236. View

14.

Drummond M, Jefferson T . Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996; 313(7052):275-83. PMC: 2351717. DOI: 10.1136/bmj.313.7052.275. View

15.

Fanuele J, Birkmeyer N, Abdu W, Tosteson T, Weinstein J . The impact of spinal problems on the health status of patients: have we underestimated the effect?. Spine (Phila Pa 1976). 2000; 25(12):1509-14. DOI: 10.1097/00007632-200006150-00009. View

16.

Vieli M, Staartjes V, Eversdjik H, de Wispelaere M, Oosterhuis J, Schroder M . Safety and Efficacy of Anterior Lumbar Interbody Fusion for Discogenic Chronic Low Back Pain in a Short-stay Setting: Data From a Prospective Registry. Cureus. 2019; 11(8):e5332. PMC: 6777969. DOI: 10.7759/cureus.5332. View

17.

Alt V, Chhabra A, Franke J, Cuche M, Schnettler R, Le Huec J . An economic analysis of using rhBMP-2 for lumbar fusion in Germany, France and UK from a societal perspective. Eur Spine J. 2009; 18(6):800-6. PMC: 2899669. DOI: 10.1007/s00586-009-0935-7. View

18.

Gillman C, Jayasuriya A . FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021; 130:112466. PMC: 8555702. DOI: 10.1016/j.msec.2021.112466. View

19.

Takatalo J, Karppinen J, Niinimaki J, Taimela S, Nayha S, Mutanen P . Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young Finnish adults?. Spine (Phila Pa 1976). 2011; 36(25):2180-9. DOI: 10.1097/BRS.0b013e3182077122. View

20.

Kenneth Burkus J, Gornet M, Schuler T, Kleeman T, Zdeblick T . Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am. 2009; 91(5):1181-9. DOI: 10.2106/JBJS.G.01485. View